# Regeneron Pharmaceuticals, Inc.: Form 4, filed Mar 11, 2020

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 4
- Filed: 2020-03-11
- Accepted by EDGAR: Mar 11, 2020, 17:00 ET
- Period: 2020-03-09
- Accession: 0001140361-20-005506
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000114036120005506/xslF345X03/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000114036120005506/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000114036120005506/xslF345X03/form4.xml

Filed Mar 11, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-005506. Last ingested by Listed: Nov 5, 2026, 23:47 ET. No prices; not investment advice.